Our data suggest that the interaction between NEDD4 and MEKK5 efficiently inhibits the NEDD4 migration signaling (Figure 6), which may provide a new strategy for the antimetastatic therapy of lung cancer. Here, MAP3K5 is linked to lung carcinoma.